ACM
ABVX

ADAR1 Capital Management’s Abivax ABVX Stock Holding History

ADAR1 Capital Management’s Portfolio ABVX Stock Details ABVX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$240M Buy
1,804,703
+410,684
+29% +$46.5M 11.01% 1
2026
Q1 		$155M Buy
1,394,019
+76,690
+6% +$9.08M 9.14% 1
2025
Q4 		$178M Sell
1,317,329
-33,497
-2% -$3.65M 13.05% 1
2025
Q3 		$115M Sell
1,350,826
-1,720,514
-56% -$105M 10.77% 1
2025
Q2 		$23.5M Buy
3,071,340
+861,321
+39% +$5.61M 3.6% 6
2025
Q1 		$13.8M Buy
2,210,019
+696,626
+46% +$4.71M 2.56% 8
2024
Q4 		$11.1M Buy
1,513,393
+991,781
+190% +$9.13M 2.21% 10
2024
Q3 		$6.01M Buy
521,612
+494,612
+1,832% +$5.93M 0.98% 23
2024
Q2 		$357K Buy
27,000
+12,000
+80% +$172K 0.07% 116
2024
Q1 		$215K Buy
+15,000
New +$193K 0.05% 116

Other funds holding ABVX

TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
HI
Helikon Investments London, United Kingdom $3.35B AUM 55.08% 1-Year Est. Return
DGM
Darwin Global Management St. Helier, Jersey $3.76B AUM 342.13% 1-Year Est. Return
VPC
Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
CP
Caligan Partners New York $2.13B AUM 758.65% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return

ADAR1 Capital Management's ABVX Position: Q2 2026 in Review

ADAR1 Capital Management increased its Abivax (ABVX) stake by 29% in Q2 2026, buying an estimated $46.5M and bringing the position to 1,804,703 shares worth $240M. The position accounts for 11.01% of the portfolio, ranked #1.

ADAR1 Capital Management first reported a position in ABVX in Q1 2024 and has held it in 10 quarters since. 302 funds tracked by Wall St. Rank hold ABVX as of Q2 2026.

  • ADAR1 Capital Management held 1,804,703 shares of Abivax worth $240M as of Q2 2026.
  • ADAR1 Capital Management bought 410,684 Abivax shares in Q2 2026, an estimated $46.5M.
  • Abivax made up 11.01% of ADAR1 Capital Management's portfolio in Q2 2026, its #1 holding.
  • ADAR1 Capital Management first reported a position in Abivax in Q1 2024 and has held it in 10 quarters since.
  • 302 funds tracked by Wall St. Rank held Abivax as of Q2 2026.

Based on ADAR1 Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.